New to The Street / Newsmax TV Announces its Four Corporate Interviews on Episode #437, Broadcast, Saturday, February 11, 2023, 3:30 PM ET


NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street / Newsmax TV announces the broadcasting line-up of its nationally syndicated show Saturday, February 11, 2023, at 3:30 PM ET.

New to The Street's 437th TV show line-up features the following four (4) corporate interviews:

1). Biopharmaceutical - Tonix Pharmaceuticals, Inc.'s (NASDAQ: TNXP) ($TNXP) interview with Dr. Seth Lederman, MD, and CEO.

2). Hemp Cigarettes - Hempacco Co., Inc.'s (NASDAQ: HPCO) ($HPCO) interviews with Sandro Piancone, Co-Founder/CEO.

3). Sustainable Solutions - The Sustainable Green Team, Ltd.'s (OTCQX: SGTM) ($SGTM) interview with Tony Raynor, Founder, President, and CEO, and Sunny Trinh, CEO, DevvStream Holdings, Inc. (NEO: DESG).

4).  "Sekur Privacy & Sekur Security Segment" interview with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) (Sekur®).

Episode #437

From the Nasdaq MarketSite studio, Dr. Seth Lederman, MD, CEO of Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) ($TNXP) ("Tonix"), talks with New to The Street's TV Host Jane King. As a clinical-stage biopharmaceutical Company, Tonix Pharmaceuticals, Inc. aims to improve health through the innovation of vaccines and therapies. Seth explains that current monoclonal antibody treatments used against COVID-19 no longer work and are no longer available in the market. The new COVID variants rendered those antibody treatments useless against the virus. In December 2022, Tonix entered into a license agreement with Curia Global, Inc. to develop three (3) humanized murine monoclonal antibodies for the treatment and prevention of COVID. Monoclonal antibody treatments are usually for patients who are very old, with medical comorbidities, and with compromised immune systems. Seth looks to help organ transplant recipients with compromised immune systems with a treatment. These patients get sick very quickly. Currently, Tonix is in the developmental stage of the monoclonal antibodies, and once FDA-approved, many patients can benefit. Seth tells viewers that the shareholder value proposition looks strong. And recently, a large institutional buyer became a large shareholder in TNXP. The on-screen QR code is available during the show; download or visit Tonix Pharmaceuticals, Inc. - https://www.tonixpharma.com/.

TV Host Jane King interviews Hempacco Co., Inc.'s (NASDAQ: HPCO) ($HPCO) Co-Founder/CEO, Sandro Piancone. Hempacco's mission is to become the largest disrupter of the $1T tobacco industry with its hemp Disrupting Tobacco™ products. The Company's hemp cigarettes are a better smoking alternative than tobacco-based products. Sandro tells views about the Company's recent announcement, establishing a joint venture (JV) with iconic celebrity, "Snoop Dogg." The JV company, HPDG, LLC., based in California, is a consumer goods company that will develop hemp-derived products, including rolling paper, gummies, chocolates, vapes, and blunt wraps. Snoop Dogg is very much involved in R&D, packaging, marketing, and other business positions. Hempacco will utilize its low-odor and spray-on terpene technologies for developed and sold products through HPDG, LLC. Sandro believes Snoop Dogg's worldwide fame will create the next level of consumer excitement with the "Snoop Dogg" hemp brands. Hempacco Co., Inc. and with their JV partners expect strong growth ahead. Sandro hopes to have Snoop Dogg as a guest on a future New to The Street episode. The on-screen QR code is available during the show; download or visit Hempacco Co., Inc.https://hempaccoinc.com/ & https://realstuffsmokables.com/.

Tony Raynor, Founder, President, and CEO of The Sustainable Green Team, Ltd. (OTCQX: SGTM) ($SGTM) and Sunny Trinh, CEO of DevvStream Holdings, Inc. (NEO: DESG) ("DevvStream") are with TV Host Jane King at the Nasdaq MarketSite studio. Tony Raynor brings Sunny Trinh on the show to talk about DevvStream's unique approach to providing capital funding for sustainable projects in exchange for carbon credits. DevvStream generates and manages these credits on its technologically advanced blockchain network. Management looks to fund companies in the renewable energy sectors, energy efficiency industries, and entities that reduce/eliminate CO2 emissions. While at a United Nations symposium, Tony attended Sunny's presentation about DevvStream and their approach to sustainability. Tony realized that The Sustainable Green Team and DevvStream have goods and services which can benefit each other. SGTM deploys and develops innovative solutions to mitigate tree/wood waste and other byproducts. As a vertically-integrated business with many subsidiaries, SGTM takes wood waste products from many sources and converts the wood fiber raw materials into usable products for the farming and agriculture industries. Sunny explains how the collaboration works so that SGTM can generate and utilize its carbon credits. Generated from every ton of carbon emission reduction, issued carbon credits are valuable and value-added to SGTM's operations. Sunny says SGTM is a perfect entity to create and utilize carbon credits and sell credits as possible additional income streams. Many industries are looking for ways to reduce their carbon footprint and seek innovative ideas to achieve "Net-Zero." The carbon credit marketplace is a $90B industry with upside growth. Sunny is introducing SGTM to a Canadian logging company that can utilize SGMT's methods and business practices to assist the logging company in reducing its carbon footprint. Large entities use the DevvStream platform and work with these large corporations to bring their products and technologies into small markets to help further sustainable outcomes. The Sustainable Green Teams collaboration with DevvStream looks to have lots of synergistic value. The on-screen QR code is available during the show; download or visit The Sustainable Green Team - https://www.thesustainablegreenteam.com/ and DevvStream - https://devvstream.com/.

New to the Street TV re-airs its "Weekly Sekur Privacy & Sekur Security Segment" with internationally acclaimed internet privacy expert Mr. Alain Ghiai, CEO of Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) and TV Co-Host / Multi-media Journalist Ana Berry. Morgan Stanley, a larger financial institution, is fining employees up to $1M for using WhatsApp messenger to communicate with clients. Alain explains that last year the US Government fined financial institutions about $2B for using open-platform communication apps for communicating with clients and sending private financial details. Most likely, the higher an employee status is at Morgan Stanley, the higher the fines. Employees know better than to use a non-secure platform to send and communicate sensitive details amongst themselves and their clients. Most people prefer text messaging platforms to email and direct phone calls. SekurMessenger is the solution, with a closed-loop encryption product protected through the Company's HeliX Technology platform. The product offers archiving required for a certain period of years for financial institutions to store and save e-communication records. Sekur expects in March 2023 that SekurMessenger will offer multiple user management interface features, allowing the Company to approach Small-Medium Businesses (SMBs) and larger corporations for a private and secure solution for their organizations. Even if the recipient is not a Sekur subscriber, their related communications are encrypted, too. The "Chat-by-Invite" is available in many countries, offering end-users a secure SMS text platform. America Movil, a Latin American telecommunication provider, is a Sekur client using the solution. Open platforms like Signal and WhatsApp have limited cybersecurity features and always ask for phone numbers when downloading the app. Hackers use phone numbers as the entry source for cybersecurity breaches on devices. Sekur never asks for phone numbers, and subscribers get their unique 6-digit number when they become subscribers, used as their Sekur electronic ID. The Company, its employees, and all its products/services focus on a culture of privacy and security. All electronic communications are through the Company's owned and maintained data servers in Switzerland, a country with the strictest privacy laws in the world. Sekur never uses 3rd parties, never mines/sell data, and has no request for phone numbers. Alain offers viewers who would like to subscribe to Sekur to use PROMO CODE: PRIVACY, a 15% savings on monthly and yearly service plans. Yearly-subscribers get the first two months free, and with the promo code, a subscriber is saving even more. The on-screen QR code is available during the show; download or visit Sekur Private Data, Ltd. – https://www.sekurprivatedata.com/ & http://www.Sekur.com. "What is your privacy worth?"  The interview is an updated segment that aired on February 4, 2023.

Tonix Pharmaceuticals Holding Corp.1 (NASDAQ: TONX) ($TONX)

Tonix Pharmaceuticals Holding Corp.(NASDAQ :TONX) ($TONX) is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's portfolio comprises central nervous system (CNS), rare disease, immunology, and infectious disease product candidates. Tonix's CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. Tonix's lead CNS candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablet), is in mid-Phase 3 development for managing fibromyalgia with a new Phase 3 study launched in the second quarter of 2022 and interim data expected in the second quarter of 2023. TNX-102 SL is also being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix initiated a Phase 2 study in Long COVID in the third quarter of 2022. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted Breakthrough Therapy designation by the FDA. A Phase 2 study of TNX-1300 is expected to be initiated in the second quarter of 2023. TNX-1900 (intranasal potentiated oxytocin), a small molecule in development for chronic migraine, is being studied in a potential pivotal Phase 2 study that initiated enrollment in the first quarter of 2023. TNX-601 ER (tianeptine hemioxalate extended-release tablets) is a once-daily formulation of tianeptine being developed as a potential treatment for major depressive disorder (MDD) with a Phase 2 study expected to be initiated in the first quarter of 2023. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for treating Prader-Willi syndrome. The FDA has granted TNX-2900 Orphan Drug designation. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the second quarter of 2023. Tonix's infectious disease pipeline includes a vaccine in development to prevent smallpox and monkeypox, TNX-801, a next-generation vaccine to prevent COVID-19, TNX-1850, a platform to make fully human monoclonal antibodies to treat COVID-19, TNX-3600, and humanized anti-SARS-CoV-2 monoclonal antibodies, TNX-3800, recently licensed from Curia. TNX-801, Tonix's vaccine in development to prevent smallpox and monkeypox, also serves as the live virus vaccine platform or recombinant pox vaccine (RPV) platform for other infectious diseases. A Phase 1 study of TNX-801 is expected to be initiated in the second half of 2023.1All of Tonix's product candidates are investigational new drugs or biologics and have not been approved for any indication; 2Noyce RS, et al. (2018) PLoS One. 13(1):e0188453; 3Tulman ER, et al. (2006) J Virol. 80(18):9244-58.PMID:16940536; 4Tonix Press Release March 16, 202a https://ir.tonixpharma.com/news-events/press-releases/detail/1255/tonix-pharmaceuticals-reports-positive-covid-19-vaccine; 5Schrick L et al. (2017) N Engl J Med. 377:1491; 6Qin et al. (2015) J. Virol. 89:1809; 7Jenner E. "An Inquiry Into the Causes and Effects of the Variolae Vaccinae: A Disease Discovered in Some of the Western Counties of England, Particularly Gloucestershire, and Known by the Name of the Cow Pox." London: Sampson Low, 1798;. 8Brinkmann A et al, Genome Biology (2020) 21:286 https://doi.org/10.1186/s13059-020-02202-0; 9Duggan A et al. Genome Biology (2020) 21:175 https://doi.org/10.1186/s13059-020-02079-z; 10Tonix press release. December 4, 2020 https://ir.tonixpharma.com/news-events/press-releases/detail/1236/vaccine-genome-researchers-report-99-7-colinear-identity; 11Trindale GS et al. (2016) Viruses (12). Pii: E328. PMID:27973399; 12Esparza E, et al (2017) Vaccine. 35(52):7222-7230.; 13Esparza J et al. (2020) Vaccine.; 38(30):4773-4779; 14 www.cdc.gov/poxvirus/monkeypox/about.html; 15 www.cdc.gov/smallpox/research/; 16Mandavilli, A. The New York Times. May 26, 2020. "Who is protected against monkeypox;" 17 www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html - Accessed February 8, 2023; 18 https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease– Accessed February 8, 2023; 19 https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease - Accessed February 8, 2023. Further information about Tonix can be found at www.tonixpharma.com.

About Hempacco Co., Inc. (NASDAQ: HPCO) ($HPCO):

Hempacco Co., Inc.'s (NASDAQ: HPCO) ($HPCO) goal is Disrupting Tobacco's™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brands. Hempacco's operational segments include manufacturing of smokables and hemp rolling paper, smokable technology development, The Real Stuff™ brand of functional smokables and rolling paper, and Cheech & Chong Hemp Cigarettes and Hemp Hop Smokables with Rick Ross. Learn more at hempaccoinc.com and order products at www.realstuffsmokables.com.

About The Sustainable Green Team, Ltd. (OTCQX: SGTM) ($SGTM)

The Sustainable Green Team, Ltd. (OTCQX: SGTM) ($SGTM) is a wholesale manufacturer and national supplier of wood-based mulch, soil, including the soil amendment products: HumiSoil® and XLR8®, which are lumber products. The Company sells directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores, food stores, and wholesale distributors. The Company's primary corporate objective is to provide a solution for treating and handling tree debris that has been historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation; visit: https://www.thesustainablegreenteam.com or visit SGTM's YouTube Channel.

About DevvStream Holdings, Inc. (NEO: DESG):

DevvStream Holdings, Inc. (NEO: DESG) ("DevvStream") is a technology-based ESG company that advances the development and monetization of environmental assets with an initial focus on carbon markets. The Company works with governments and corporations worldwide to achieve their sustainability goals. DevvStream's management looks to implement curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air—creating carbon credits in the process. The business enables us to provide direct non-dilutive capital to our clients while empowering them with field-proven, technology-based solutions to improve their climate impact quickly. The Company manages all environmental assets created through our projects by a proprietary blockchain-based ESG software platform designed explicitly to ensure transparency and auditability, with full data provenance, significantly increasing asset value. DevvStream's business model includes mutual collaboration and partnership with Devvio (www.devv.io), a leading ESG-focused blockchain company; Global Green (www.globalgreen.org), an international nonprofit that helps governments and Fortune 100 companies meet their climate goals; Marmota (www.marmota.ca), a Canada-based JV specializing in environmental asset creation, green project management, emissions mitigation, and sustainable financing for municipal, provincial and federal governments; and United Cities North America, an affiliate of the United Nations with a focus on building sustainable and net-zero smart cities and communities. For more information, visit www.devvstream.com.

About Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0):

Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted emails, and secure communication tools. It sells its products through its websites www.sekur.com, approved distributors, and telecommunication companies worldwide. Sekur Private Data, Ltd. serves consumers, businesses, and governments worldwide - https://www.sekurprivatedata.com and https://www.sekur.com; Twitter: @sekurprivate.

About New to The Street:

New to the Street is an FMW Media production that operates one of the longest-running US and International sponsored and syndicated Nielsen Rated programming television brands, "New to The Street," and its blockchain show, "Exploring The Block." Since 2009, these brands have run biographical interview segment shows across major U.S. television networks. The paid-for-television programming platforms can potentially reach over 540 million homes in the US and international markets. FMW's New to The Street / Newsmax televised broadcasting platform airs its syndication on Saturdays at 3:30 – 4:00 PM ET. FMW is also one of the nation's largest buyers of linear television, long and short-form paid programming - https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at which such performance or results are achieved. This press release should be considered in all filings of the Companies contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

CONTACT:

FMW Media Contacts:
+1 (631) 766-7462
Bryan@NewToTheStreet.com

"New to The Street" Business Development Office
1-516-696-5900
Support@NewToTheStreet.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/498dd0f0-b2b4-482e-9272-128e7cbbd256


NTTSNew